Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)

Leukemia. 2023 Aug;37(8):1741-1744. doi: 10.1038/s41375-023-01967-0. Epub 2023 Jul 11.

Dikelele Elessa^#¹, Lin-Pierre Zhao^#², Rafael Daltro de Oliveira², Nabih Maslah^{3

4}, Juliette Soret-Dulphy², Emmanuelle Verger^{3

4}, Clémence Marcault², Nathalie Parquet³, Pierre Fenaux⁵, Lionel Adès⁵, Emmanuel Raffoux⁵, Stéphane Giraudier^{3

4}, Olivier Fain¹, Bruno Cassinat^{3

4}, Jean-Jacques Kiladjian^{2

4}, Arsene Mekinian⁶, Lina Benajiba^{7

8}

¹ Sorbonne Université, Service de médecine interne et inflammation, Saint-Antoine Hospital, APHP, Paris, France.
² Université Paris Cité, Clinical Investigations Center, Saint-Louis Hospital, APHP, Paris, France.
³ Université Paris Cité, Cellular biology Department, Saint-Louis Hospital, APHP, Paris, France.
⁴ INSERM UMR 1131, Saint-Louis Research Institute, Paris, France.
⁵ Université Paris Cité, Hematology Department, Saint-Louis Hospital, APHP, Paris, France.
⁶ Sorbonne Université, Service de médecine interne et inflammation, Saint-Antoine Hospital, APHP, Paris, France. arsene.mekinian@aphp.fr.
⁷ Université Paris Cité, Clinical Investigations Center, Saint-Louis Hospital, APHP, Paris, France. lina.benajiba@aphp.fr.
⁸ INSERM UMR 944, Saint-Louis Research Institute, Paris, France. lina.benajiba@aphp.fr.

^# Contributed equally.

No abstract available

Publication types